Have you been diagnosed with pancreatic adenocarcinoma? If so, you may be a good fit to help us learn if combination treatment with specific drugs may stimulate the body's immune system against cancer cells.

Do you want to experience a nurturing, empowering and wellness-centered prenatal care that helps you reduce the chance of getting diabetes in pregnancy? Then the Targeted Lifestyle Change (TLC) Study might be for you! TLC is specially designed to help you learn how to eat, move, and live for two during pregnancy to explore whether we can reduce the risks of diabetes in pregnancy. Compensation provided.

Have you been diagnosed with Multiple Myeloma? Have you received idecabtagene vicleucel (ide-cel (Abecma)) CAR-T treatment? If so, you may be able to take part in a research study looking at for how long a new drug called iberdomide will keep Multiple Myeloma under control (in remission).

Have you been diagnosed with large B-cell lymphoma (LBCL) and have not yet received treament? If so, you may be able to take part in a research study looking at the efficacy of giving a drug called glofitamab in combination with other drugs. The drugs are: polatuzumab vedotin (Pola) (also known as Polivy→) and rituximab (R) (also known as Rituxan→ and MabThera→), as well as a group of chemotherapy drugs, cyclophosphamide (C), doxorubicin (H), and prednisone (P) (referred to as Pola-R-CHP).

What factors influence how the brain takes in sugar to use it as energy? If you are between the ages of 18-45 years old and are healthy and of normal weight, you might be eligible to participate in this study to help us understand how the way sugar enters the body affects how sugar enters the brain.

Efgartigimod has been approved by the U.S. FDA (Food and Drug Administration) as a treatment for adult patients with gMG in whom AChR-Ab's are present. However, it was not approved it for the form of gMG that is AChR Ab seronegative (antibodies not present). and therefore this study is now testing how efragtigimod works in patients without any antibodies,

Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AK117 to patients with Leukemia

Do you have Hidradenitis Suppurativa (HS)? You may be eligible to participate in a research study assessing the effect of an investigational product in HS and its impact on quality of life. If eligible, and you decide to participate, you will receive the study drug study related medical evaluation and compensation for completed visits.

Have you been diagnosed with s Cutaneous (skin) Lymphoma? If so this could be a good study for you to paticipate in. One of the primary goals of the USCLC is to establish a registry of patients with cutaneous lymphoma in the United States. Such a registry would collect information such as the specific cutaneous lymphoma diagnosis, stage of disease, treatments used, and response to treatments. This information will collected on an online Institutional Review Board (IRB)-approved database/registry of patients from all sites. We hope that this will allow providers to better understand this rare disease by looking at data from many patients. We hope ultimately will include all the patients with cutaneous lymphoma across the United States

If you have NMOSD, you are between the ages of 18 and 60, and you use a smart phone, you may be able to participate in a clinical trial testing a new self-assessment tool app. Compensation provided.